Use of cross-linked amylose as a matrix for the slow release...

Details Use of cross-linked amylose as a matrix for the slow release... Use of cross-linked amylose as a matrix for the slow release...

A - Human Necessities

61

K

A61K 9/36 (2006.01)

Patent

CA 2041774

ABSTRACT OF THE DISCLOSURE The present invention is concerned with a solid slow release oral pharmaceutical dosage unit which comprises a solid dosage unit made up of an admixture of a therapeutic dosage of an orally effective pharmaceutical product and a cross-linked polymer of amylose with a cross-linking agent selected from 2,3 dibromopropanol and epichlorohydrin, wherein the cross-linking of the polymer has been carried out with from about 0.1 to about 10 g of cross-linking agent per 100 g of amylose.

Affiliated with

Also associated with

Rating

Use of cross-linked amylose as a matrix for the slow release... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cross-linked amylose as a matrix for the slow release..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cross-linked amylose as a matrix for the slow release... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1858492